RU486 increases radiosensitivity and restores apoptosis through modulation of HPV E6/E7 in dexamethasone-treated cervical carcinoma cells

Gynecologic Oncology

Volumn 77, Issue 1, 2000, Pages 177-182

  Kamradt, Merideth C ^a   Mohideen, Najeeb ^a   Vaughan, Andrew T M ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DNA FRAGMENT; LIPOCORTIN 5; MESSENGER RNA; MIFEPRISTONE; PROTEIN P53;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PRIORITY JOURNAL; RADIOSENSITIVITY; UTERINE CERVIX CARCINOMA;

EID: 0034005997     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5724     Document Type: Article

References (30)

1. Walboomers J M, Jacobs M V, Manos M M, Bosch F X, Kummer J A, Shah K V, Snijders P J, Peto J, Meijer C J, Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:1999;12-19.
2. Lazo P A. The molecular genetics of cervical carcinoma. Br J Cancer. 80:1999;2008-2018.
3. Werness B A, Levine A J, Howley P M. Association of HPV types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
4. Gloss B, Bernard H U, Seedorf K, Klock G. The upstream regulatory region of the human papillomavirus contains an E2 protein independent enhancer which is specific for cervical carcinoma and regulated by glucocorticoid hormones. EMBO. 6:1991;3735-3743.
5. Von Knebel Doeberitz M, Tilman O, Schwarz E, Gissmann L. Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cell lines. Cancer Res. 48:1988;3780-3786.
6. Von Knebel Doeberitz M, Bauknecht T, Bartsch D, ZurHausen H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6/E7 in cervical carcinoma cells. Proc Natl Acad Sci USA. 88:1991;1411-1415.
7. Von Knebel Doeberitz M, Ritmuller C, Zur Hausen H, Durst M. Inhibition of tumorigenicity of cervical cells in nude mice by HPV E6/E7 antisense RNA. Int J Cancer. 55:1992;831-834.
8. Von Knebel Doeberitz M, Koch S, Drzonek H, ZurHausen H. Glucocorticoid hormones reduce the expression of major histocompatibility class I antigens on human epithelial cells. Eur J Immunol. 20:1990;35-40.
9. Keys H M, Bundy B N, Stehman F B, Muderspach L I, Chafe W E, Suggs C L 3rd, Walker J L, Gersell D. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 340:1999;1154-1161.
10. Rose P G, Bundy B N, Watkins E B, Thigpen J T, Deppe G, Maiman M A, Clarke-Pearson D L, Insalaco S. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med. 340:1999;1144-1153.
11. Morris M, Eifel P J, Lu J, Grigsby P W, Levenback C, Stevens R E, Rotman M, Gershenson D M, Mutch D G. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med. 340:1999;1137-1143.
12. Kamradt M C, Mohideen N, Krueger E, Walter S, Vaughan A TM. Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma depends upon increased HPV E6/E7. Br J Cancer. 2000.
13. Scheffner M, Werness B A, Huibregtse J M, Levine A J, Howley P M. The E6 oncoprotein encoded by HPV types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
14. Huibregtse J M, Scheffner M, Howley P M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 13:1991;4129-4135.
15. Butz K, Whitaker N, Denk C, Ullmann A, Geisen C, Hoppe-Seyler F. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Oncogene. 18:1999;2381-2386.
16. Butz K, Geisen C, Ullmann A, Spitovsky D, Hoppe-Seyler F. Cellular responses of HPV-positive cancer cells to genotoxic anti-cancer agents, repression of E6/E7-oncogene expression and induction of apoptosis. Int J of Cancer. 68:1996;506-513.
17. Butz K, Shahabeddin L, Geisen C, Spitovsky P, Ullmann A, Hoppe-Seyler F. Functional p53 protein in human papillomavirus-positive cancer cells. Oncogene. 10:1995;927-936.
18. Pater M M, Hughes G A, Hyslop D E, Nakshatri H, Pater A. Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA. Nature. 335:1988;832-835.
19. Pater M M, Pater A. RU486 inhibits glucocorticoid hormone-dependent oncogenesis by Human Papillomavirus type 16 DNA. Virology. 183:1991;799-802.
20. Von Knebel Doeberitz M, Bauknecht T, Bartsch D, ZurHausen H. Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6/E7 in cervical carcinoma cells. Proc Natl Acad Sci USA. 88:1991;1411-1415.
21. Yu Y, Little J B. p53 is involved in but not required for ionizing radiation-induced caspase-3 activation and apoptosis in human lymphoblast cell lines. Cancer Res. 58:1998;4277-4281.
22. Tsang N M, Nagasawa H, Li C, Little J B. Abrogation of p53 function by transfection of HPV16 E6 gene enhances the resistance of human diploid fibroblasts to ionizing radiation. Oncogene. 10:1995;2403-2408.
23. Brown J M, Wouters B G. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. Cancer Res. 59:1999;1391-1399.
24. Rutz H P, Mariotta M, von Knebel Doeberitz M, Mirimanoff R O. Dexamethasone-induced radioresistance occurring independent of human papilloma virus gene expression in cervical carcinoma cells. Strahlenther Onkol. 174:1998;71-74.
25. Lowe S W, Schmitt E A, Smith S W, Osbourne B A, Jacks T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature. 362:1993;847-849.
26. Clark A R, Purdie C A, Harrison D J, Morris R G, Bird C C, Hooper M L, Wyllie A H. Thymocyte dependent apoptosis induced by p53-dependent and independent pathways. Nature. 362:1993;849-852.
27. Aldridge D R, Radford I R. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines. Cancer Res. 58:1998;2817-2824.
28. Ling C C, Guo M, Chen C H, Deloherey T. Radiation-induced apoptosis: Effects of cell age and dose fractionation. Cancer Res. 55:1995;5207-5212.
29. Rupnow B A, Murtha A D, Alarcon R M, Giaccia A J, Knox S J. Direct evidence that apoptosis enhances tumor responses to fractionated radiotherapy. Cancer Res. 58:1998;1779-1784.
30. West C ML, Davidson S E, Roberts S A, Hunter R D. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J of Cancer. 68:1993;819-823.